Becker's Healthcare June 13, 2024
A year and a half after four organizations and four physicians filed a lawsuit against the FDA’s approval of mifepristone to terminate a pregnancy, the Supreme Court unanimously ruled June 13 in favor of the FDA.
The dispute has been winding its way through the courts since November 2020, when four organizations and four physicians sued the FDA over its 2000 approval of mifepristone. The drug is part of a two-drug regimen indicated to end a pregnancy in the first 10 weeks of gestation.
The regimen accounts for 63% of all abortions in the U.S., according to the Guttmacher Institute.
The FDA approved mifepristone in 2000 to end a pregnancy within the first seven weeks,...
Today's Sponsors
Today's Sponsor